KruppLBBanwellBTenembaumS. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology2007; 68: S7–S12.
2.
KruppLBTardieuMAmatoMP. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler2013; 19: 1261–1267.
LotzeTENorthropJLHuttonGJ. Spectrum of pediatric neuromyelitis optica. Pediatrics2008; 122: e1039–e1047.
6.
MarSLenoxJBenzingerT. Long-term prognosis of pediatric patients with relapsing acute disseminated encephalomyelitis. J Child Neurol2010; 25: 681–688.
7.
DundarNAnlarBGuvenA. Relapsing acute disseminated encephalomyelitis in children: Further evaluation of the diagnosis. J Child Neurol2010; 25: 1491–1497.
8.
PolmanCHReingoldSCBanwellB. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol2011; 69: 292–302.
9.
ReindlMDi PauliFRostasyK. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol2013; 9: 455–461.
10.
MayerMCBreithauptCReindlM. Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol2013; 191: 3594–3604.
11.
SelterRCBrilotFGrummelV. Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases. Neurology2010; 74: 1711–1715.
12.
Di PauliFMaderSRostasyK. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol2011; 138: 247–254.
13.
LalivePHHäuslerMGMaureyH. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult Scler2011; 17: 297–302.
14.
PröbstelAKDornmairKBittnerR. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology2011; 77: 580–588.
15.
RostasyKMaderSHennesEM. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler2013; 19: 1052–1059.
16.
HacohenYAbsoudMWoodhallM. Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. J Neurol Neurosurg Psychiatry2014; 85: 456–461.
17.
HacohenYAbsoudMDeivaK. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm2015; 2: e81 (in press).
18.
Hino-FukuyoNHaginoyaKNakashimaI. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies. Brain Dev2015. Available at: http://dx.doi.org/10.1016/j.braindev.2015.02.006 (in press).
19.
HuppkePRostasyKKarenfortM. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler2013; 19: 941–946.
20.
RostasyKMaderSSchandaK. Anti-MOG antibodies in children with optic neuritis. Arch Neurol2012; 69: 752–756.
21.
MiyauchiAMondenYWatanabeM. Persistent presence of the anti-myelin oligodendrocyte glycoprotein autoantibody in a pediatric case of acute disseminated encephalomyelitis followed by optic neuritis. Neuropediatrics2014; 45: 196–199.
